{{Rsnum
|rsid=4727963
|Gene=SLC13A1
|Chromosome=7
|position=123119926
|Orientation=plus
|GMAF=0.3907
|Gene_s=SLC13A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 23.9 | 58.4 | 17.7
| HCB | 50.0 | 39.7 | 10.3
| JPT | 41.6 | 48.7 | 9.7
| YRI | 34.7 | 44.9 | 20.4
| ASW | 24.6 | 57.9 | 17.5
| CHB | 50.0 | 39.7 | 10.3
| CHD | 47.2 | 40.7 | 12.0
| GIH | 29.7 | 40.6 | 29.7
| LWK | 36.4 | 44.5 | 19.1
| MEX | 43.1 | 44.8 | 12.1
| MKK | 41.7 | 46.8 | 11.5
| TSI | 33.3 | 46.1 | 20.6
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=1E-6
  |OR=2.09
  |ORtxt=[1.505-2.914]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}